An Orally Administered Small Molecule That Inhibits Hepatic Sulfatase-2 Expression In Vivo: A Novel Strategy to Correct Diabetic Dyslipoproteinemia With Implications for Residual Atherosclerotic Cardiovascular Disease (ASCVD) Risk

CIRCULATION(2017)

引用 0|浏览6
暂无评分
关键词
Triglycerides,Diabetes Mellitus,Lipoproteins,Receptors,Apolipoproteins
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要